Henry James International Management Inc. Lowers Holdings in Smith & Nephew plc (NYSE:SNN)

Henry James International Management Inc. decreased its position in Smith & Nephew plc (NYSE:SNN) by 7.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 189,686 shares of the medical equipment provider’s stock after selling 15,338 shares during the period. Smith & Nephew accounts for about 2.1% of Henry James International Management Inc.’s investment portfolio, making the stock its 15th biggest position. Henry James International Management Inc.’s holdings in Smith & Nephew were worth $5,907,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the company. Brandes Investment Partners LP boosted its holdings in shares of Smith & Nephew by 20.5% in the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after purchasing an additional 233,293 shares during the period. Bank of Montreal Can boosted its holdings in shares of Smith & Nephew by 355.8% in the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock valued at $31,059,000 after purchasing an additional 964,762 shares during the period. Hsbc Holdings PLC lifted its holdings in Smith & Nephew by 18.9% during the second quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock worth $13,607,000 after buying an additional 87,360 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Smith & Nephew by 58.2% during the second quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after buying an additional 193,046 shares during the period. Finally, Deprince Race & Zollo Inc. lifted its holdings in Smith & Nephew by 94.2% during the second quarter. Deprince Race & Zollo Inc. now owns 239,245 shares of the medical equipment provider’s stock worth $5,928,000 after buying an additional 116,078 shares during the period. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Stock Performance

Smith & Nephew stock opened at $24.99 on Monday. Smith & Nephew plc has a twelve month low of $23.65 and a twelve month high of $31.72. The business has a fifty day moving average of $29.98 and a two-hundred day moving average of $27.84. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on SNN. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Monday, August 5th. Deutsche Bank Aktiengesellschaft lowered Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.